Chemosaturation With Percutaneous Hepatic Perfusion of Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A Single Center Experience

Cancer Imaging - United Kingdom
doi 10.1186/s40644-019-0218-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Chemosaturation With Percutaneous Hepatic Perfusion for Unresectable Metastatic Melanoma or Sarcoma to the Liver: A Single Institution Experience

Journal of Surgical Oncology
MedicineSurgeryOncology
2013English

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”

Case Reports in Oncological Medicine
Oncology
2019English

Isolated Hepatic Perfusion With 200 Mg Melphalan for Advanced Noncolorectal Liver Metastases

Annals of Surgical Oncology
OncologySurgery
2008English

Intra-Arterial Perfusion-Based Therapies for Regionally Metastatic Cutaneous and Uveal Melanoma

Melanoma Management
DermatologyOncology
2019English

Hepatic Resection for Isolated Breast Cancer Liver Metastasis: A Single-Center Experience

Korean Journal of Clinical Oncology
2017English

Isolated Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases (The SCANDIUM Trial): Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2014English

Review of Regional Limb Perfusion With Melphalan for Malignant Melanoma

BMJ
1966English

Hepatic Yttrium-90 Radioembolization Treatment of Patients With Liver Dominant Metastatic Renal Cell Cancer - The Moffitt Experience

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2015English

Nestin Expression in Primary and Metastatic Uveal Melanoma - Possible Biomarker for High-Risk Uveal Melanoma

Acta Ophthalmologica
MedicineOphthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy